Nasdaq Gets a Healthy Dose of Psychedelics With Lucy Scientific

February 17, 2023 · Yahoo!Finance

Lucy Scientific Discovery Inc. (Nasdaq: LSDI), which focuses on psychotropic drugs and had its initial public offering last week, rang the closing bell at the Nasdaq stock exchange today in New York.

The company is focused on becoming the premier research, development, and manufacturing organization for the emerging psychedelics-based medicines industry, it said in a statement.

“This milestone marks a significant step in the company’s growth and plans for expansion,” said CEO Chris McElvany. “We look forward to the opportunities ahead of us to continue working on improving mental health and finding sustainable solutions for treatment.”

Mind-bending psychedelics including MDMA (aka “ecstasy”), “magic mushrooms” and LSD are being studied as potential treatments for depression, post-traumatic stress disorder and addiction. Dozens of companies and academic laboratories are also making changes to the structure of those drugs, or designing similar compounds, to take advantage of their therapeutic properties without the high.

Psychedelic drugs including psilocybin and LSD could help patients grow new neural connections in the brain, some studies in animals and people suggest. The trip, together with therapy, likely help people shift their mind-set and process past experiences, changing their outlook and patterns of thinking.

The company’s Board is led by Executive Chairman Richard Nanula, a former Executive Vice President and CFO at the Walt Disney Co., as well as executive roles as the COO of Starwood Hotels, EVP of Finance and Strategy at Amgen.

Separately, Lucy Scientific filed an amendment to its current Dealer’s License with Health Canada to add cocaine and heroin.

The company said the expansion represents an effort to supply harm reduction programs globally. It criticized the “failed war on drugs” and said the company seeks to “reduce lethal and or negative consequences associated with adulterated drug supply, particularly considering that fentanyl overdose is the leading cause of deaths among 18 to 45-year-olds in the United States.”

The company already has licenses from Health Canada to make psilocybin, MDMA, LSD and mescaline. (Full Story)

In categories:Finance Psychedelics
Next Post

What’s it like to take a $249 drug-free psychedelic trip? We found out

I’m familiar with magic mushrooms from back in the day. I took them a couple times in college — including on a particularly memorable Halloween — and thoroughly enjoyed the experience. So I was curious about a Santa Monica-based startup…
Read
Previous Post

Novel Combination Of Cannabis-Like Compound With Classical Psychedelics Searches IP Coverage In US

Israeli-based next-gen psychedelics biotech Clearmind Medicine  CMND+0.83%+ Free Alerts together with partner clinical-stage pharma company SciSparc SPRC-0.44%+ Free Alerts has filed three provisional patent applications with the United States Patent and Trademark Office (USPTO). The patents cover psychedelic-based therapeutics, including monotherapy and novel combinations…
Read
Random Post

Dutchie Founders Ross & Zach Lipson Leave Dutchie

BEND, Oregon–According to a press release, Ross and Zach Lipson, who co-founded the privately held Oregon company, have resigned from their positions of leadership, and the board of directors has selected a new chief executive officer, chief financial officer, general…
Read
Random Post

As part of rebranding effort, off-Strip boutique hotel wants to be ‘cannabis-inclusive’

A Las Vegas off-Strip hotel plans to have an entire floor of cannabis-friendly rooms. Under new ownership by Elevations Hotels & Resorts, the Artisan Hotel Boutique will be rebranded as The Lexi. Officials at the 64-room property near Interstate 15…
Read
Random Post

Cannabis Entrepreneur Asks $38 Million for L.A. Mansion With Custom Smoking Room

Cannabis entrepreneur Ori Bytton is asking $38 million for a Los Angeles mansion with a custom smoking room.  Mr. Bytton, 36, hails from Israel and is the founder of the cannabis products company Natura Life Science. He acquired the Bel-Air…
Read
Random Post


Kristin Cavallari opens up about Bufo experience: 'It was a spiritual detox'

Kristin Cavallari is getting candid about her experience with Bufo therapy, motherhood and dating after divorce. On Tuesday, the former "Laguna Beach" star made an appearance on the latest episode of Kaitlyn Bristowe's podcast, "Off The Vine," where she gave fans "the tea"…
Read